Repligen (RGEN) Current Deferred Revenue (2011 - 2026)

Repligen (RGEN) has reported Current Deferred Revenue for 15 consecutive years, with $19.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 5.81% year-over-year to $19.6 million in Q2 2026; TTM through Jun 2026 was $19.6 million, a 5.81% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, up 10.31% from the prior year.
• Current Deferred Revenue was $19.6 million for Q2 2026 at Repligen, up from $18.3 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $31.6 million in Q2 2023 and troughed at $13.2 million in Q4 2024.
• A 5-year average of $20.1 million and a median of $19.4 million in 2022 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue jumped 54.95% in 2023 and slumped 55.64% in 2024, its largest moves.
• Over 5 years, Current Deferred Revenue stood at $19.3 million in 2022, then retreated by 11.49% to $17.1 million in 2023, then dropped by 22.41% to $13.2 million in 2024, then advanced by 10.31% to $14.6 million in 2025, then surged by 34.15% to $19.6 million in 2026.
• The last three Current Deferred Revenue figures came in at $19.6 million (Q2 2026), $18.3 million (Q1 2026), and $14.6 million (Q4 2025), per Business Quant data.